LONGATO, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.492
EU - Europa 412
AS - Asia 147
OC - Oceania 5
SA - Sud America 3
AF - Africa 2
Totale 2.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.488
IT - Italia 206
CN - Cina 96
SE - Svezia 45
DE - Germania 31
FI - Finlandia 26
FR - Francia 26
GB - Regno Unito 23
IN - India 22
PT - Portogallo 21
VN - Vietnam 14
ES - Italia 9
IE - Irlanda 6
AU - Australia 5
HK - Hong Kong 5
KR - Corea 5
CA - Canada 4
CZ - Repubblica Ceca 4
RU - Federazione Russa 4
JP - Giappone 3
NL - Olanda 3
BE - Belgio 2
CH - Svizzera 2
NG - Nigeria 2
BR - Brasile 1
EC - Ecuador 1
GR - Grecia 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 2.061
Salva come PNG Salva come JPEG
Città #
Chandler 242
Fairfield 217
Ashburn 133
Woodbridge 89
Cambridge 83
Wilmington 81
Seattle 78
Houston 75
Ann Arbor 65
Padova 47
Beijing 43
Medford 33
Princeton 33
San Diego 30
Des Moines 23
Helsinki 23
Roxbury 23
Pune 17
Lisbon 15
Dong Ket 14
New York 13
Turin 12
Milan 11
Boardman 10
Florence 10
Rome 8
Venice 7
Dublin 6
Guangzhou 6
Limana 6
Madrid 6
Nanjing 6
London 5
Moncalieri 5
Pavia 5
Yeongdeungpo-gu 5
Arzignano 4
Kilburn 4
Los Angeles 4
Nanchang 4
Ogden 4
Pilsen 4
Treviso 4
Vicenza 4
Amsterdam 3
Borås 3
Boston 3
Carcavelos 3
Duncan 3
Jinan 3
Naples 3
Newham 3
Norwalk 3
Ottawa 3
Paese 3
Paris 3
Perth 3
Verona 3
Washington 3
Zhengzhou 3
Bagnaria Arsa 2
Belluno 2
Breganze 2
Brendola 2
Busto Arsizio 2
Changsha 2
Chennai 2
Chiampo 2
Delhi 2
Fulham 2
Jesolo 2
Kortenberg 2
Lagos 2
Lappeenranta 2
Lumezzane 2
Marcallo con Casone 2
Massy 2
Mestrino 2
Monza 2
Nuremberg 2
Olbia 2
Philadelphia 2
Pioltello 2
San Giorgio del Sannio 2
Shanghai 2
Shenyang 2
Taizhou 2
Tianjin 2
Accrington 1
Acton 1
Agordo 1
Ahmedabad 1
Amadora 1
Bagheria 1
Baotou 1
Bari 1
Berlin 1
Bradford 1
Bratislava 1
Caparica 1
Totale 1.633
Salva come PNG Salva come JPEG
Nome #
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 115
Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data 104
Importance of Recalibrating Models for Type 2 Diabetes Onset Prediction: Application of the Diabetes Population Risk Tool on the Health and Retirement Study 88
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 86
HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability 85
Detecting Undiagnosed Diabetes: Proof-of-Concept Based on the Health-Information Exchange System of the Veneto Region (North-East Italy) 81
Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin 80
Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices 80
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis 71
Addressing practical issues of predictive models translation into everyday practice and public health management: A combined model to predict the risk of type 2 diabetes improves incidence prediction and reduces the prevalence of missing risk predictions 67
A CONSENSUS MODEL TO IMPROVE THE PREDICTION OF TYPE 2 DIABETES ONSET: VALIDATION ON THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS DATA 63
A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models 62
Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy) 60
Overview of iDPP@CLEF 2022: The Intelligent Disease Progression Prediction Challenge 58
Support vector machine fed by CGM-based glycemic variability indices can distinguish between IGT and T2D subjects 52
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice 52
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes 51
IGT and T2D subjects automatically classified using a selection of CGM-based glycemic variability indices 48
Prevalence and impact of diabetes among people infected with SARS-CoV-2 48
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life 47
Building a predictive model of diabetes from Veneto’s regional HIE: identification of patients from administrative data 46
Ranking physiological, lifestyle and environmental risk factors for predicting type 2 diabetes onset 42
Prediction of Cardiovascular Complications in Diabetes from Pharmacy Administrative Claims 41
Overview of iDPP@CLEF 2023: The Intelligent Disease Progression Prediction Challenge 38
CGM-based glycemic variability indices allow accurate classification of IGT and T2D subjects 37
A Deep Learning Approach to Predict Diabetes' Cardiovascular Complications from Administrative Claims 37
Long-term cardiovascular outcome after intensive versus standard screening of diabetic complications: a real-word observational study 33
Selected articles from the 17th International Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2021) 32
Manual and automatic identification of ACMG evidence in scientific papers 32
Comparing the Predictive Power of Heart Failure Hospitalisation Risk Scores in the Diabetic Outpatient Clinic and Primary Care Settings 30
Validation and recalibration of the Finnish Diabetes Risk Score on the older American population of the Health and Retirement Study 29
Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2022 25
Baseline Machine Learning Approaches To Predict Amyotrophic Lateral Sclerosis Disease Progression 25
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study 23
Predicting clinical outcomes of amyotrophic lateral sclerosis progression using logistic regression and deep-learning multilayer perceptron approaches 21
Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims 21
Recurrent Neural Network to Predict Renal Function Impairment in Diabetic Patients via Longitudinal Routine Check-up Data 21
Comparing the Predictive Power of Heart Failure Hospitalisation Risk Scores Across Different Care Settings 21
Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2022 20
Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin 20
Dealing with Data Scarcity in Rare Diseases: Dynamic Bayesian Networks and Transfer Learning to Develop Prognostic Models of Amyotrophic Lateral Sclerosis 19
Baseline Machine Learning Approaches To Predict Multiple Sclerosis Disease Progression 14
Computational Intelligence Methods for Bioinformatics and Biostatistics - 17th International Meeting, CIBB 2021, Virtual Event, November 15–17, 2021, Revised Selected Papers 14
Explainable Deep-Learning Model Reveals Past Cardiovascular Disease in Patients with Diabetes Using Free-Form Visit Reports 13
Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review 12
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studies 11
Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims 9
Towards automatic ACMG evidence identification for variant interpretation 9
Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care 9
Time-series analysis of multidimensional clinical-laboratory data by dynamic Bayesian networks reveals trajectories of COVID-19 outcomes 9
DAVI: A Dataset for Automatic Variant Interpretation 6
Selected articles from the 17th International Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2021) 5
Deep-learning-based natural-language-processing models to identify cardiovascular disease hospitalisations of patients with diabetes from routine visits' text 3
Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis 2
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 1
Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2023 1
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care 1
Totale 2.130
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.359
article - articoli 5.982
book - libri 0
conference - conferenze 0
curatela - curatele 252
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 251
Totale 16.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201947 0 0 0 0 0 0 0 0 0 8 21 18
2019/2020259 13 2 5 42 22 14 23 19 40 37 29 13
2020/2021397 22 19 12 17 62 36 9 33 53 37 47 50
2021/2022426 16 29 17 33 25 37 30 51 32 10 20 126
2022/2023488 78 67 34 36 56 50 2 33 56 15 34 27
2023/2024476 27 58 57 46 24 62 52 79 34 37 0 0
Totale 2.130